Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 271

1.

Medication adherence and the use of long-acting antipsychotics in bipolar disorder.

El-Mallakh RS.

J Psychiatr Pract. 2007 Mar;13(2):79-85. Review.

PMID:
17414683
2.

Adherence and assured administration of medications in bipolar patients.

El-Mallakh PL, El-Mallakh RS.

Curr Drug Deliv. 2013 Dec;10(6):706-12.

PMID:
24033263
3.

Depot antipsychotic medications in bipolar disorder: a review of the literature.

Bond DJ, Pratoomsri W, Yatham LN.

Acta Psychiatr Scand Suppl. 2007;(434):3-16. Review.

PMID:
17688458
4.

What is the evidence for the use of second-generation antipsychotic long-acting injectables as maintenance treatment in bipolar disorder?

Samalin L, Nourry A, Charpeaud T, Llorca PM.

Nord J Psychiatry. 2014 May;68(4):227-35. doi: 10.3109/08039488.2013.801078. Epub 2013 Jun 24. Review.

PMID:
23795859
5.

Treatment adherence with antipsychotic medications in bipolar disorder.

Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV.

Bipolar Disord. 2006 Jun;8(3):232-41.

6.

Antidepressants and antipsychotics in the long-term treatment of bipolar disorder.

Kusumakar V.

J Clin Psychiatry. 2002;63 Suppl 10:23-8. Review.

7.
8.

Antipsychotic medications in the treatment of bipolar disorder.

Surja AA, Tamas RL, El-Mallakh RS.

Curr Drug Targets. 2006 Sep;7(9):1217-24. Review.

PMID:
17017897
9.

Atypical antipsychotics and mood stabilization in bipolar disorder.

Brambilla P, Barale F, Soares JC.

Psychopharmacology (Berl). 2003 Apr;166(4):315-32. Epub 2003 Feb 27. Review.

PMID:
12607072
10.

[French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].

Samalin L, Abbar M, Courtet P, Guillaume S, Lancrenon S, Llorca PM.

Encephale. 2013 Dec;39 Suppl 4:189-203. doi: 10.1016/S0013-7006(13)70121-0. French.

PMID:
24373464
11.

A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia.

Bhanji NH, Chouinard G, Margolese HC.

Eur Neuropsychopharmacol. 2004 Mar;14(2):87-92. Review.

PMID:
15013023
12.
13.

Patients' reports of the factors influencing medication adherence in bipolar disorder - an integrative review of the literature.

Crowe M, Wilson L, Inder M.

Int J Nurs Stud. 2011 Jul;48(7):894-903. doi: 10.1016/j.ijnurstu.2011.03.008. Epub 2011 Apr 9. Review.

PMID:
21481391
14.

A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone.

Vieta E, Nieto E, Autet A, Rosa AR, Goikolea JM, Cruz N, Bonet P.

World J Biol Psychiatry. 2008;9(3):219-24. doi: 10.1080/15622970701530917.

PMID:
18609430
15.

Depot antipsychotics in bipolar affective disorder.

White E, Cheung P, Silverstone T.

Int Clin Psychopharmacol. 1993 Summer;8(2):119-22.

PMID:
8102150
16.

Differential prescription of maintenance antipsychotics to African American and white patients with new-onset bipolar disorder.

Fleck DE, Hendricks WL, DelBello MP, Strakowski SM.

J Clin Psychiatry. 2002 Aug;63(8):658-64.

PMID:
12197445
17.
18.

Enhancing medication adherence in patients with bipolar disorder.

Berk L, Hallam KT, Colom F, Vieta E, Hasty M, Macneil C, Berk M.

Hum Psychopharmacol. 2010 Jan;25(1):1-16. doi: 10.1002/hup.1081. Review. Erratum in: Hum Psychopharmacol. 2010 Mar;25(2):192.

PMID:
20041478
19.
20.

Factors associated with medication adherence in African American and white patients with bipolar disorder.

Fleck DE, Keck PE Jr, Corey KB, Strakowski SM.

J Clin Psychiatry. 2005 May;66(5):646-52.

PMID:
15889954

Supplemental Content

Support Center